Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Communication Disorders × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Lymphoid 1 CNS 1

Conditions

Brain Neoplasms 429 Glioma 208 Glioblastoma 198 Neoplasms 59 Breast Neoplasms 53 Central Nervous System Neoplasms 52 Neuroblastoma 50 Meningioma 45 Astrocytoma 40 Neuroma, Acoustic 35 Spinal Cord Neoplasms 33 Neurofibromatosis 1 30 Oligodendroglioma 28 Sarcoma 27 Lung Neoplasms 27 Lymphoma 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Neoplasm Metastasis 24 Melanoma 22 Head and Neck Neoplasms 22 Lymphoma, Non-Hodgkin 21 Leukemia 21 Hodgkin Disease 20 Meningeal Carcinomatosis 19 Burkitt Lymphoma 19 Testicular Neoplasms 18 Lymphoma, Follicular 18 Prostatic Neoplasms 17 Multiple Myeloma 17 Motor Activity 17

Interventions

Speech Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05189366 2025-10-07

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡